ABSTRACT

Diabetes mellitus is an endocrinological and/or metabolic disorder with an increasing global prevalence and incidence. Diabetes Mellitus is a group of physiological dysfunctions characterized by hyperglycaemia resulting directly from insulin resistance, inadequate insulin secretion or excessive glucagon secretion. It has many sub-classifications including Type-1, Type-2, Gestational Diabetes and Steroid-Induced Diabetes. Type-1 and Type-2 Diabetes Mellitus are the main sub-types each with different pathophysiology, management but both have a potential for hyperglycaemia. The risk of Adverse Drug Reactions (ADRs) was especially high for patients with diabetes undergoing chemotherapy. It important to learn about Adverse Drug Reactions, because ADRs are one of the leading causes of morbidity and mortality in healthcare. One-third of people with diabetes experience at least one Adverse Drug Reaction. Biguanides, peptide hormones and sulphonyl urea are the classes of Antidiabetics drugs and amongst them most commonly used drugs are “Metformin and Insulin”. Mostly ADRs were related to the endocrine and gastrointestinal system. In this article we aimed to evaluate the Adverse Drug Reaction incidence in patients suffering with Diabetes Mellitus. Keywords: Diabetes mellitus, Endocrinological, Hyperglycemia, Juvenile diabetes, Gestational diabetes
Publication date: 01/07/2024

https://ijbpas.com/pdf/2024/July/MS_IJBPAS_2024_8159.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2024/13.7.8159